Trillium Therapeutics Inc. (9)
Browse by Contract Category
Contracts
-
Change in Control Severance Policy, effective as of August 20, 2021
(Filed With SEC on November 12, 2021)
-
Arrangement Agreement dated as of August 20, 2021, among Trillium Therapeutics Inc., Pfizer Inc. and PF Argentum Acquisition ULC
(Filed With SEC on August 23, 2021)
-
Indenture between Trillium Therapeutics Inc. and Penwest Revenue Corp., dated as of May 26, 2015
(Filed With SEC on March 18, 2021)
-
Lease Agreement between Trillium Therapeutics USA Inc. and PPF OFF 100 Cambridge Park Drive, LLC, dated as of December 10, 2018
(Filed With SEC on March 18, 2021)
-
Form of Indemnification Agreement
(Filed With SEC on March 18, 2021)
-
Employment Agreement between Trillium Therapeutics Inc. and Benjamin Looker effective April 26, 2021
(Filed With SEC on May 7, 2021)
-
Description of the Registrants Securities
(Filed With SEC on March 18, 2021)
-
Executive Employment Agreement between Trillium Therapeutics Inc. and Dr. Jan Skvarka effective September 25, 2019
(Filed With SEC on March 18, 2021)
-
Executive Employment Agreement between Trillium Therapeutics Inc. and Dr. Ingmar Bruns effective November 2, 2020
(Filed With SEC on March 18, 2021)